Sisu Pharma Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.7M

  • Investors
  • 2

Sisu Pharma General Information

Description

Developer of medications designed to treat prostate cancer. The company's drugs can directly target the transcription factor Heat Shock Factor and offer additional opportunities to develop therapies for neurodegenerative conditions and infections, enabling patients to be treated for cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • San Diego, CA
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • San Diego, CA
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sisu Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 19-Oct-2020 $1.7M Completed Pre-Clinical Trials
To view Sisu Pharma’s complete valuation and funding history, request access »

Sisu Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed +
Seed
To view Sisu Pharma’s complete cap table history, request access »

Sisu Pharma Patents

Sisu Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025240416-A1 Compositions and methods for the treatment of cancer Pending 13-May-2024
WO-2025240412-A1 Methods for the treatment of cancer Pending 13-May-2024
US-20240317727-A1 Compositions and methods for the treatment of cancer Pending 11-Dec-2018 C07D409/12

Sisu Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sisu Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
JMCR Family Office Family Office Minority
Viva Ventures Biotech Group Venture Capital Minority
To view Sisu Pharma’s complete investors history, request access »

Sisu Pharma FAQs

  • When was Sisu Pharma founded?

    Sisu Pharma was founded in 2019.

  • Where is Sisu Pharma headquartered?

    Sisu Pharma is headquartered in San Diego, CA.

  • What is the size of Sisu Pharma?

    Sisu Pharma has 2 total employees.

  • What industry is Sisu Pharma in?

    Sisu Pharma’s primary industry is Drug Discovery.

  • Is Sisu Pharma a private or public company?

    Sisu Pharma is a Private company.

  • What is the current valuation of Sisu Pharma?

    The current valuation of Sisu Pharma is .

  • What is Sisu Pharma’s current revenue?

    The current revenue for Sisu Pharma is .

  • How much funding has Sisu Pharma raised over time?

    Sisu Pharma has raised $1.7M.

  • Who are Sisu Pharma’s investors?

    JMCR Family Office and Viva Ventures Biotech Group have invested in Sisu Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process